Loma Negra Compania Industrial Argentina SA (LOMA)
Buenos Aires Exchange · Argentina · prices in ARS · close of 23 Oct 2026
Key indicators
| Last close | ARS 3,220.00 |
|---|---|
| 52-week range | 2,469.00 – 4,130.00 |
| Return, 1 month / 3 months | +5.3% / −14.5% |
| Return, 1 year / 3 years | +27.4% / +180.2% |
| Trend | Below its 200-day average |
| RSI (14) | 55 |
| Volatility (1 year) | 41.0% |
| Worst drawdown (1 year) | -28.2% |
| Average daily value traded | 909.17M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Loma Negra Compania Industrial Argentina is a cement and building materials producer based in Argentina. The company makes and sells cement, masonry cement, lime and concrete products, serving construction firms, builders and other customers across the country. Its plants and distribution network supply both large building projects and smaller construction work, and the business also provides related services such as transport and concrete pumping to its customers.
The shares are listed on the Buenos Aires Exchange in Argentina under the code LOMA, and the price on this page is in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Loma Negra Compania Industrial Argentina SA (LOMA) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 3,220.00 on 23 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 92 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 27.4% and over the last three months it fell 14.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.0% | ||
| From 52-week high | -20.3% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.5% | ||
| 6-month return | -2.8% | ||
| 12-month return, skipping the last month | 21.0% | ||
| Stability (higher is calmer) | 50 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 41.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.2% | ||
| Liquidity | 77 · Strong | Trades actively. | |
| Average daily value traded | 909.17M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.2% |
|---|---|
| 1 month | +5.3% |
| 3 months | −14.5% |
| 6 months | −2.8% |
| 1 year | +27.4% |
| 3 years | +180.2% |
| 5 years | +1,186.0% |
Signals
| 50-day / 200-day average | 3,109.75 / 3,319.24 |
|---|---|
| Golden / death cross (60 days) | Death, 41 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 121.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Jan 2023 | ARS 5.9965 |
| 8 Jul 2022 | ARS 17.5948 |
| 22 Apr 2022 | ARS 8.7974 |
| 9 Oct 2020 | ARS 4.0267 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.